TLSA
TLSA
NASDAQ · Biotechnology

Tiziana Life Sciences Ltd

$0.61
-0.01 (-1.69%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +6,114.6% upside
Low Target $25.58
Average Target $37.94
High Target $45.71
Current Price $0.61
Current
$0.61
Target
$37.94
$25.58 $37.94 avg $45.71
Scenario Analysis
Bear Case
$25.58
4,090.0%
Low target
Base Case
$37.94
+6,114.6%
Avg target
Bull Case
$45.71
+7,387.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.90
-67.9% from high
52-Week Low
$0.57
+7.7% from low
Target vs 52W High
$37.94
+1,896.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%